In PAH patients treated with specific PAH-oriented therapy right atrial enlargement, impaired right ventricular systolic function, as well as increased BNP and bilirubin concentration was associated with an increased mortality risk. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.